Are certain genetic profiles more susceptible to GLP-1 related hair loss
Youll need your self-inject pen, an alcohol swab and a sharps container for safely disposing of the needle after use
The initial dose of retatrutide is 0.5 mg, which is injected subcutaneously once weekly
They want to maintain the same protocol for months or years until they achieve a desired weight-loss result

Decision framework: Start existing treatments (semaglutide or tirzepatide) if: Your health risks from obesity are significant and immediate (uncontrolled diabetes, severe sleep apnea, cardiovascular disease) You have access to approved therapies through insurance or can afford them You need proven, FDA-approved medications with established safety profiles Waiting 1-2+ years for retatrutide approval doesnt align with your health timeline Consider waiting if: Youre currently at a stable weight with controlled health conditions Youve tried semaglutide or tirzepatide and hit a plateau but tolerated them well Youre in a position to potentially enroll in a retatrutide clinical trial You understand waiting means continued health risks from obesity Dont wait if: You think retatrutide will be a magic bullet with no downsides Your doctor is recommending treatment now for medical reasons Youre using waiting for the next best thing as an excuse to avoid addressing the problem The lifestyle component is non-negotiable regardless of which medication you use: High protein intake (0.7-1g per pound of body weight daily) to preserve muscle during weight loss

Running GHK-Cu during active fat loss, rather than after, puts these regenerative signals in place while the extracellular matrix is most responsive to remodeling stimulus